Immediate Impact
50 standout
Citing Papers
Metabolic reprogramming in the tumor microenvironment of liver cancer
2024 Standout
Lung cancer in patients who have never smoked — an emerging disease
2024 Standout
Works of A. Bertolini being referenced
CNS response to osimertinib vs standard of care (SoC) EGFR-TKI as first-line therapy in patients (pts) with EGFR-TKI sensitising mutation (EGFRm)-positive advanced non-small cell lung cancer (NSCLC): Data from the FLAURA study
2017
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy: a phase II ITMO study
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A. Bertolini | 109 | 109 | 27 | 69 | 37 | 298 | |
| Brendan McNeish | 94 | 89 | 16 | 35 | 23 | 284 | |
| Tetsuyo Maeda | 102 | 81 | 26 | 30 | 26 | 326 | |
| Fang Cui | 124 | 40 | 28 | 32 | 46 | 335 | |
| Beatrice Dufrusine | 121 | 40 | 9 | 30 | 28 | 299 | |
| A. Jobke | 51 | 33 | 69 | 47 | 29 | 309 | |
| Jingyi Yang | 95 | 50 | 37 | 42 | 40 | 263 | |
| Yunchao Wang | 94 | 112 | 25 | 75 | 42 | 328 | |
| An Wang | 94 | 34 | 20 | 40 | 38 | 304 | |
| Heng-Chen Yao | 91 | 34 | 30 | 55 | 35 | 318 | |
| Lamers Cb | 42 | 78 | 8 | 139 | 29 | 317 |
All Works
Login with ORCID to disown or claim papers
Loading papers...